2017 saw a spike in investor confidence and complacency, as volatility fell significantly and appetite for risk fueled many stocks higher. Chad Morganlander, Portfolio Manager at Washington Crossing Advisors, was with us to discuss whether he expects more of the same for the year ahead.
Morganlander says we are at point in the market cycle where global growth is predictable in the short-term. His firm is somewhat optimistic, but aware that valuations are becoming quite stretched, he adds. Morganlander believes markets are entering a period of low growth for next several years, predicting a 4% to 6% return in U.S. equities.
One of Morganlander's top picks for the year is Hershey’s. He suggests investors stick with "big and boring" companies. With Hershey's, investors can go to sleep for 3-5 years and wake up with tremendous returns, according to Morganlander. Hershey's has also entered a bid for Nestle's U.S. confectionary business, which includes brands such as Butterfunger and Baby Ruth. The potential acquisition is not baked in to Washington Crossing Advisor's outlook. He also recommends shares of Hormel Foods and Dr Pepper Snapple.
Seth Schachner, Managing Director at Strat Americas, on Hollywood's latest blockbusters utilizing content creation. Plus, the future of YouTube and TikTok.
Ashley Gold, Axios' Tech/Policy reporter, discusses what the future of Google and search engines will look like after the tech giant faces an antitrust trial.
A labor rights group has alleged that Starbucks sourced coffee from a major Brazilian cooperative whose member farms were cited for keeping workers in slave-like conditions.
X, the social media platform owned by Trump adviser Elon Musk, is challenging the constitutionality of a Minnesota ban on using deepfakes to influence elections and harm candidates.
Seth Goldstein, Equity Strategist at Morningstar, breaks down Tesla's earnings report, talks Musk's future with the company and how stocks have responded.
Senior Health Correspondent for TIME, Alice Park, gives us a deeper look into how Eli Lilly's new pill orforglipron may change the healthcare industry.
Archer Aviation CEO Adam Goldstein talks about the advancements in electric air taxis and how his company is changing the future of air transportation. Watch!
